Volume 6, Issue 4 (Nov 2018)                   Res Mol Med (RMM) 2018, 6(4): 38-47 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousavi H, Rouhani nejad H, Zandi M, Khodavirdipour A. Antimicrobial Effect of Multilayered Carbon Nanotubes on Multi-Drug-Resistant Pseudomonas aeruginosa . Res Mol Med (RMM) 2018; 6 (4) :38-47
URL: http://rmm.mazums.ac.ir/article-1-292-en.html
1- Department of Microbiology, Faculty of Science, Islamic Azad University, Hamedan, Hamedan, Iran
2- Malek-Ashtar University of Technology, Tehran, Iran , rohaninejhad@gmail.com
3- Department of Nursing and Midwifery, Tuyserkan Branch, Islamic Azad University, Tuyserkan, Iran
4- Division of Human Genetics, department of anatomy, St. John’s hospital, Bangalore, INDIA
Abstract:   (2790 Views)
Background: Pseudomonas aeruginosa is the primary cause of infection with impaired defense mechanisms. P. aeruginosa commonly causes nosocomial infections and is the most common pathogen isolated from patients hospitalized for longer than 1 week. We examined the antimicrobial effect of multilayered carbon nanotubes on multi-drug-resistant.
Materials and methods: In this research, 20 clinical isolates collected at Motahari Hospital (Tehran, Iran) were compared with the standard (ATCC 27853) and identified as P. aeruginosa based on biochemical testing. Conventional disk diffusion assay demonstrated the methicillin resistance of the isolates. Minimal inhibitory concentrations for antibiotics and the multilayer CNTs were determined using the microdilution method. Single-walled CNTs were prepared and their efficacy and potential  synergism with antibiotics was assessed.
Results: Synergism against P. aeruginosa was evident for methicillin + single-walled CNTs.
Conclusion: The inhibitory effect of single-walled CNTs and methicillin was synergistic against the growth of P. aeruginosa.
Full-Text [PDF 481 kb]   (1242 Downloads)    
Type of Study: Research | Subject: Biotechnology
Published: 2018/11/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Research in Molecular Medicine

Designed & Developed by : Yektaweb